Masahiko Tanabe

1.5k total citations
90 papers, 882 citations indexed

About

Masahiko Tanabe is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Masahiko Tanabe has authored 90 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 30 papers in Cancer Research and 21 papers in Surgery. Recurrent topics in Masahiko Tanabe's work include Breast Cancer Treatment Studies (23 papers), Breast Lesions and Carcinomas (15 papers) and HER2/EGFR in Cancer Research (12 papers). Masahiko Tanabe is often cited by papers focused on Breast Cancer Treatment Studies (23 papers), Breast Lesions and Carcinomas (15 papers) and HER2/EGFR in Cancer Research (12 papers). Masahiko Tanabe collaborates with scholars based in Japan, United States and Ireland. Masahiko Tanabe's co-authors include Yasuyuki Seto, Takaaki Konishi, Hideo Yasunaga, Yoshiya Horimoto, Michimasa Fujiogi, Mitsue Saito, Atsushi Arakawa, Shigeaki Kato, Saya Ito and Eriko Suzuki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Masahiko Tanabe

81 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masahiko Tanabe Japan 15 323 290 251 148 147 90 882
María Dirlei Begnami Brazil 19 390 1.2× 323 1.1× 158 0.6× 66 0.4× 172 1.2× 51 961
Salvatore Vieni Italy 17 196 0.6× 374 1.3× 243 1.0× 218 1.5× 295 2.0× 58 1.1k
Jędrzej Grzegrzółka Poland 18 466 1.4× 427 1.5× 259 1.0× 84 0.6× 87 0.6× 76 1.1k
Karolina Przybyłowska Poland 17 379 1.2× 241 0.8× 303 1.2× 103 0.7× 62 0.4× 48 828
Takakazu Sasaguri Japan 16 217 0.7× 183 0.6× 83 0.3× 97 0.7× 126 0.9× 40 777
Łukasz Szylberg Poland 17 314 1.0× 367 1.3× 211 0.8× 86 0.6× 156 1.1× 81 923
Byung Wook Min South Korea 17 280 0.9× 375 1.3× 127 0.5× 154 1.0× 225 1.5× 58 862
Maria Melachrinou Greece 17 231 0.7× 166 0.6× 93 0.4× 81 0.5× 123 0.8× 54 722
Zhizhong Ye China 19 327 1.0× 124 0.4× 227 0.9× 75 0.5× 73 0.5× 58 1.1k
Daniela Kodetová Czechia 12 256 0.8× 186 0.6× 112 0.4× 93 0.6× 130 0.9× 35 779

Countries citing papers authored by Masahiko Tanabe

Since Specialization
Citations

This map shows the geographic impact of Masahiko Tanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiko Tanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiko Tanabe more than expected).

Fields of papers citing papers by Masahiko Tanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiko Tanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiko Tanabe. The network helps show where Masahiko Tanabe may publish in the future.

Co-authorship network of co-authors of Masahiko Tanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiko Tanabe. A scholar is included among the top collaborators of Masahiko Tanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiko Tanabe. Masahiko Tanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ogawa, Miho, Kousuke Watanabe, Aya Shinozaki‐Ushiku, et al.. (2025). Germline pathogenic variants detected by GenMineTOP: insight from a nationwide tumor/normal paired comprehensive genomic profiling test, in Japan. Journal of Human Genetics. 71(1). 1–11.
2.
Saito, Yuki, Hidenori Kage, Kenya Kobayashi, et al.. (2024). Comprehensive genomic profiling from C‐CAT database unveiled over 80% presence of oncogenic drivers in anaplastic thyroid carcinoma including BRAF, RAS family, NF1, and FGFR1. Clinical Endocrinology. 101(2). 170–179. 6 indexed citations
3.
4.
Konishi, Takaaki, Michimasa Fujiogi, Misuzu Sato, et al.. (2023). Impact of the National Action Plan for Antimicrobial Resistance on Antibiotic Use for Mastitis Using a Japanese Nationwide Database. Breast Care. 18(2). 122–129. 2 indexed citations
5.
Tanabe, Masahiko, et al.. (2023). Post-traumatic growth and cancer-related communication among adolescents having mothers with breast cancer. Supportive Care in Cancer. 31(7). 446–446. 1 indexed citations
6.
Konishi, Takaaki, Michimasa Fujiogi, Nobuaki Michihata, et al.. (2022). Cost-effectiveness analysis of trastuzumab monotherapy versus adjuvant chemotherapy plus trastuzumab in elderly patients with HER2-positive early breast cancer. Japanese Journal of Clinical Oncology. 52(10). 1115–1123. 8 indexed citations
7.
Konishi, Takaaki, Michimasa Fujiogi, Daisuke Shigemi, et al.. (2022). Surgical and obstetric outcomes of breast cancer surgery during pregnancy: a nationwide database study in Japan. Breast Cancer Research and Treatment. 195(3). 289–299. 8 indexed citations
8.
Konishi, Takaaki, Takeshi Takamoto, Michimasa Fujiogi, et al.. (2022). Laparoscopic versus open distal pancreatectomy with or without splenectomy: A propensity score analysis in Japan. International Journal of Surgery. 104. 106765–106765. 7 indexed citations
9.
Konishi, Takaaki, Michimasa Fujiogi, Nobuaki Michihata, et al.. (2022). Interstitial lung disorders following postoperative radiotherapy with concurrent or sequential hormonal therapy for breast cancer: a nationwide database study in Japan. Breast Cancer. 29(4). 688–697. 3 indexed citations
10.
Konishi, Takaaki, Masahiko Tanabe, Nobuaki Michihata, et al.. (2022). Risk factors for arm lymphedema following breast cancer surgery: a Japanese nationwide database study of 84,022 patients. Breast Cancer. 30(1). 36–45. 8 indexed citations
11.
Tanabe, Masahiko, et al.. (2021). Circulating Tumor DNA Harboring the BRAF V600E Mutation May Predict Poor Outcomes of Primary Papillary Thyroid Cancer Patients. Thyroid. 31(12). 1822–1828. 10 indexed citations
12.
13.
Konishi, Takaaki, Tadahiro Goto, Michimasa Fujiogi, et al.. (2021). New machine learning scoring system for predicting postoperative mortality in gastroduodenal ulcer perforation: A study using a Japanese nationwide inpatient database. Surgery. 171(4). 1036–1042. 10 indexed citations
14.
Konishi, Takaaki, Michimasa Fujiogi, Nobuaki Michihata, et al.. (2020). Comparing outcomes of nonoperative treatment for adhesive small bowel obstruction with and without antibiotics. Journal of Infection and Chemotherapy. 27(5). 690–695. 3 indexed citations
15.
Horimoto, Yoshiya, Masahiko Tanabe, Kaoru Mogushi, et al.. (2019). Estrogen Receptor-positive Ductal Carcinoma In Situ Frequently Overexpresses HER2 Protein Without Gene Amplification. The American Journal of Surgical Pathology. 43(9). 1221–1228. 6 indexed citations
16.
Horimoto, Yoshiya, Masahiko Tanabe, Yuko Ichikawa, et al.. (2018). Predictive markers for efficacy of everolimus plus exemestane in patients with luminal HER2-negative metastatic breast cancer. Medical Oncology. 35(4). 48–48. 7 indexed citations
17.
Horimoto, Yoshiya, Atsushi Arakawa, Masahiko Tanabe, et al.. (2015). Menstrual cycle could affect Ki67 expression in estrogen receptor-positive breast cancer patients. Journal of Clinical Pathology. 68(10). 825–829. 10 indexed citations
18.
Horimoto, Yoshiya, Atsushi Arakawa, Narumi Harada‐Shoji, et al.. (2014). Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases. British Journal of Cancer. 112(2). 345–351. 26 indexed citations
19.
Horimoto, Yoshiya, Atsushi Arakawa, Masahiko Tanabe, et al.. (2014). Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer. BMC Cancer. 14(1). 550–550. 22 indexed citations
20.
Ishitobi, Makoto, Yasuhiro Okumura, Reiki Nishimura, et al.. (2013). Repeat lumpectomy for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: the impact of radiotherapy on second IBTR. Breast Cancer. 21(6). 754–760. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Dirlei Begnami Breakdown of academic impact, for papers by Salvatore Vieni Breakdown of academic impact, for papers by Jędrzej Grzegrzółka Breakdown of academic impact, for papers by Karolina Przybyłowska Breakdown of academic impact, for papers by Takakazu Sasaguri Breakdown of academic impact, for papers by Łukasz Szylberg Breakdown of academic impact, for papers by Byung Wook Min Breakdown of academic impact, for papers by Maria Melachrinou Breakdown of academic impact, for papers by Zhizhong Ye Breakdown of academic impact, for papers by Daniela Kodetová
Rankless by CCL
2026